Skip to main content
. 2022 Nov 1;11(21):6496. doi: 10.3390/jcm11216496

Table 1.

Demographics of study population according to serum zinc level.

Total Serum Zinc Group
Low,
0.0~79.9
Low–Normal, 80.0~100.0 High–Normal, 100.1~120.0 High
120.1~320.0
p-Value
N (%) N (%) N (%) N (%) N (%)
Total 487 43 114 136 194
Serum zinc levels [mcg/dl], median (IQR) 112.0
(95.0–142.0)
69.4
(65.2–74.6)
91.2
(86.3–96.1)
109.2
(105.9–114.4)
147.7
(134.6–175.2)
Age, year, median (IQR) 67 (55–77) 64 (51–77) 71 (57–77) 68 (58–78.5) 64 (53–74) 0.09
Male sex 334 (68.6) 32 (74.4) 79 (69.3) 88 (64.7) 135 (69.6) 0.63
Education, >12 years 218 (44.8) 19 (44.2) 53 (46.5) 53 (39.0) 93 (47.9) 0.43
Pre-injury disability, GOS 1–4 9 (1.8) 2 (1.8) 4 (2.9) 3 (1.5) 0.75
Comorbidities
 Hypertension 182 (37.4) 14 (32.6) 39 (34.2) 54 (39.7) 75 (38.7) 0.71
 Diabetes mellitus 122 (25.1) 14 (32.6) 28 (24.6) 43 (31.6) 37 (19.1) 0.04
 Chronic liver disease 22 (4.5) 3 (7.0) 4 (3.5) 6 (4.4) 9 (4.6) 0.83
 Hemodialysis 18 (3.7) 7 (6.1) 8 (5.9) 3 (1.5) 0.04
 Coagulopathy 11 (2.3) 7 (6.1) 1 (0.7) 3 (1.5) 0.01
 Antiplatelet or anticoagulation 61 (12.5) 3 (7.0) 17 (14.9) 18 (13.2) 23 (11.9) 0.58
Mechanism of injury 0.02
 Road traffic injury 210 (43.1) 18 (41.9) 58 (50.9) 49 (36.0) 85 (43.8)
 Fall 204 (41.9) 12 (27.9) 44 (38.6) 66 (48.5) 82 (42.3)
 Others 73 (15.0) 13 (30.2) 12 (10.5) 21 (15.4) 27 (13.9)
Prehospital alertness 133 (27.3) 6 (14.0) 27 (23.7) 34 (25.0) 66 (34.0) 0.02
GCS in the ED, median (IQR) 15 (9–15) 12 (4–15) b,c 15 (7–15) 15 (11–15) 15 (10–15) 0.02
Laboratory findings, median (IQR)
 Hemoglobin [g/dL] 12 (10–13) 10 (8.8–11) a,b,c 11 (10–13) b,c 12 (11–13) 13 (11–14) <0.01
 Platelet [103/μL] 194 (159–244) 168 (144–228) 200 (165–242) 189 (152–245) 198 (167–244) 0.07
 PT INR 1.0 (0.9–1.1) 1.1 (1–1.2) a,b,c 1.0 (0.9–1.1) 1.0 (0.9–1.1) 1.0 (0.9–1.0) <0.01
Types of intracranial injury
 Diffuse axonal injury 34 (7.0) 4 (9.3) 6 (5.3) 7 (5.1) 17 (8.8) 0.47
 Subdural hemorrhage 359 (73.7) 30 (69.8) 84 (73.7) 99 (72.8) 146 (75.3) 0.89
 Epidural hemorrhage 74 (15.2) 8 (18.6) 13 (11.4) 28 (20.6) 25 (12.9) 0.14
 Subarachnoid hemorrhage 200 (41.1) 14 (32.6) 51 (44.7) 52 (38.2) 83 (42.8) 0.46
 Intracerebral hemorrhage 115 (23.6) 13 (30.2) 33 (28.9) 30 (22.1) 39 (20.1) 0.23
 Intraventricular hemorrhage 41 (8.4) 7 (16.3) 7 (6.1) 7 (5.1) 20 (10.3) 0.07
AIS of head injury, 3–6 407 (83.6) 38 (88.4) 100 (87.7) 110 (80.9) 159 (82.0) 0.36
Injury severity score 17 (10–25) 22 (16–27) c 19.5 (13–25) c 16 (10–25) 16 (9–22) <0.01
Transfusion in the ED 127 (26.1) 21 (48.8) b,c 41 (36.0) b,c 27 (19.9) 38 (19.6) <0.01
Any operation 138 (28.3) 14 (32.6) 30 (26.3) 42 (30.9) 52 (26.8) 0.74
Outcomes
 ED mortality 15 (3.1) 1 (2.3) 5 (4.4) 3 (2.2) 6 (3.1)
 1-month GOS 0.19
  Death 95 (19.5) 15 (34.9) 28 (24.6) 24 (17.6) 28 (14.4)
  Vegetative state 6 (1.2) 3 (2.6) 1 (0.7) 2 (1.0)
  Severe disability 45 (9.2) 3 (7.0) 8 (7.0) 14 (10.3) 20 (10.3)
  Moderate disability 38 (7.8) 4 (9.3) 8 (7.0) 9 (6.6) 17 (8.8)
  Good recovery 303 (62.2) 21 (48.8) 67 (58.8) 88 (64.7) 127 (65.5)
 6-month GOS 0.35
  Death 103 (21.1) 15 (34.9) 29 (25.4) 29 (21.3) 30 (15.5)
  Vegetative state 8 (1.6) 2 (1.8) 2 (1.5) 4 (2.1)
  Severe disability 33 (6.8) 4 (9.3) 6 (5.3) 8 (5.9) 15 (7.7)
  Moderate disability 35 (7.2) 4 (9.3) 8 (7.0) 8 (5.9) 15 (7.7)
  Good recovery 308 (63.2) 20 (46.5) 69 (60.5) 89 (65.4) 130 (67.0)

Abbreviations: IQR—interquartile range; GOS—Glasgow outcome scale; GCS—Glasgow coma scale; ED—emergency department; PT INR—prothrombin time international normalized ratio; AIS—abbreviated injury scale; a Bonferroni-adjusted p-value < 0.05 compared with the low–normal group; b Bonferroni-adjusted p-value < 0.05 compared with the high–normal group; c Bonferroni-adjusted p-value < 0.05 compared with the high group.